Congenital Hyperinsulinism
📧 Sign up to get email alerts when something new happens for Congenital Hyperinsulinism.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-08-03Clinical Trial Update: Extension Trial Evaluating the Long-term Safety and Efficacy of Dasiglucagon in Children With Congenital Hyperinsulinism [Phase 3]
Extension trial evaluating the long-term safety and efficacy of dasiglucagon in children with congenital hyperinsulinism has completed Phase…
-
CLINICAL_TRIALS trial_result · 2026-02-09Clinical Trial Update: 18F-DOPA II - PET Imaging Optimization [Phase 3]
Phase 3 trial of the imaging agent 18F-DOPA II for PET imaging optimization is currently recruiting, sponsored by the University of Alberta,…
-
CLINICAL_TRIALS trial_result · 2026-01-20Clinical Trial Update: Extension Trial Evaluating the Long-term Safety and Efficacy of Dasiglucagon in Children With Congenital Hyperinsulinism [Phase 3]
Extension Phase 3 trial assessing long-term safety and efficacy of dasiglucagon in children with congenital hyperinsulinism; study is curren…
-
CLINICAL_TRIALS trial_result · 2026-01-08Clinical Trial Update: RZ358 Treatment for Congenital Hyperinsulinism [Phase 3]
Phase 3 clinical trial update for RZ358 in congenital hyperinsulinism, with the study currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-10-01Clinical Trial Update: Continuous Glucose Monitoring in Neonatal Hyperinsulinism
A clinical trial evaluating continuous glucose monitoring for neonatal hyperinsulinism has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-05-28Clinical Trial Update: An Open-Label Multiple Dose Study of RZ358 in Patients With Congenital Hyperinsulinism [Phase 2]
Phase 2 open-label, multiple-dose study of RZ358 in congenital hyperinsulinism has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2025-03-14Clinical Trial Update: Trial Evaluating Efficacy and Safety of Dasiglucagon in Children With Congenital Hyperinsulinism [Phase 2, Phase 3]
Updated results from a Phase 2/3 trial evaluating dasiglucagon for efficacy and safety in children with congenital hyperinsulinism.
-
CLINICAL_TRIALS trial_result · 2024-07-16Clinical Trial Update: Fluorodopa F 18 in Congenital Hyperinsulinism and Insulinoma [Phase 1]
Phase 1 clinical trial evaluating fluorodopa F-18 as an imaging tracer for congenital hyperinsulinism and insulinoma. The study is currently…
-
CLINICAL_TRIALS trial_result · 2024-04-18Clinical Trial Update: Lanreotide Autogel Treatment of Patients With Congenital Hyperinsulinism of Infancy [Phase 4]
Phase 4 trial update on lanreotide Autogel for congenital hyperinsulinism of infancy has completed.
-
CLINICAL_TRIALS trial_result · 2023-12-13Clinical Trial Update: A Two-Period Open-label Trial Evaluating Efficacy and Safety of Dasiglucagon in Children With Congenital Hyperinsulinism [Phase 3]
Phase 3 open-label trial assessing dasiglucagon for efficacy and safety in children with congenital hyperinsulinism completed with results p…
-
CLINICAL_TRIALS trial_result · 2022-11-09Clinical Trial Update: Utility of [F-18] fluoroDOPA for Neonatal Hyperinsulinism [Phase 2]
Phase 2 clinical trial updating the utility of F-18 fluoroDOPA for neonatal hyperinsulinism (congenital hyperinsulinism).
-
CLINICAL_TRIALS trial_result · 2022-01-10Clinical Trial Update: 18F-DOPA PET Imaging: an Evaluation of Biodistribution and Safety [Phase 3]
Phase 3 clinical trial evaluating 18F-DOPA PET imaging for biodistribution and safety.
-
CLINICAL_TRIALS trial_result · 2021-10-15Clinical Trial Update: Phase II Safety and Efficacy Study of 18FDOPA PET-CT in Children With Hyperinsulinemic Hypoglycemia [Phase 2]
Phase II study assessing safety and efficacy of 18FDOPA PET-CT imaging in children with congenital hyperinsulinism and persistent hyperinsul…
-
CLINICAL_TRIALS trial_result · 2020-05-14Clinical Trial Update: Effect of Exendin (9-39) on Glucose Requirements to Maintain Euglycemia [Phase 1, Phase 2]
Phase 1/2 trial updates the effect of exendin (9-39) on glucose requirements to maintain euglycemia in congenital hyperinsulinism; study ter…
-
CLINICAL_TRIALS trial_result · 2019-12-10Clinical Trial Update: CSI-Glucagon for Prevention of Hypoglycemia in Children With Congenital Hyperinsulinism [Phase 2]
Phase 2 trial update for CSI-Glucagon in children to prevent hypoglycemia in congenital hyperinsulinism; results posted after completion.
-
CLINICAL_TRIALS trial_result · 2018-01-18Clinical Trial Update: Effect of Exendin-(9-39) on Fasting Adaptation and Protein Sensitivity [Phase 1, Phase 2]
Phase 1/2 trial update investigating exendin-(9-39) effects on fasting adaptation and protein sensitivity in congenital hyperinsulinism; stu…
-
CLINICAL_TRIALS trial_result · 2017-02-06Clinical Trial Update: A Single-Dose Open-Label Study of XOMA 358 in Subjects With Congenital Hyperinsulinism [Phase 2]
A Phase 2, single-dose, open-label study of XOMA 358 in subjects with congenital hyperinsulinism has completed.
-
CLINICAL_TRIALS trial_result · 2016-11-09Clinical Trial Update: Effect of Exendin-(9-39) on Glycemic Control in Subjects With Congenital Hyperinsulinism [Phase 1, Phase 2]
Clinical trial update on the effect of Exendin-(9-39) on glycemic control in congenital hyperinsulinism. The study includes Phase 1 and Phas…
-
CLINICAL_TRIALS trial_result · 2014-04-09Clinical Trial Update: Towards Individualized Surgery in Non-focal Congenital Hyperinsulinism
A completed clinical trial exploring individualized surgical approaches for non-focal congenital hyperinsulinism.
-
CLINICAL_TRIALS trial_result · 2013-12-19Clinical Trial Update: Sandostatine® LP and Hyperinsulinism [Phase 2]
A Phase 2 clinical trial evaluating Sandostatine LP for congenital hyperinsulinism has completed.